Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
0.00%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 690 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Artelo Biosciences, Inc.
Market Cap
$1.38M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.40M
Net Profit Margin
-51.26%
TTM Avg
-32.02%
3Y Avg
-93.24%
5Y Avg
-164.46%
Market Cap
$1.46M
Net Profit Margin
-70.18%
TTM Avg
-240.09%
3Y Avg
-517.75%
5Y Avg
-505.95%
Market Cap
$1.46M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.48M
Net Profit Margin
-490.33%
TTM Avg
-239.03%
3Y Avg
-377.20%
5Y Avg
-368.58%
Market Cap
$1.46M
Net Profit Margin
-522.97%
TTM Avg
-779.71%
3Y Avg
-448.59%
5Y Avg
-16114.03%
Market Cap
$1.20M
Net Profit Margin
-14220.12%
TTM Avg
-19831.38%
3Y Avg
-10446.98%
5Y Avg
-7103.54%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Artelo Biosciences, Inc. (ARTL) | $1.38M | 0.00% | 0.00% | 0.00% | 0.00% |
| NEXGEL, Inc. (NXGL)vs › | $1.40M | -51.26% | -32.02% | -93.24% | -164.46% |
| Genprex, Inc. (GNPX)vs › | $1.36M | 0.00% | 0.00% | 0.00% | 0.00% |
| NewcelX Ltd. (NCEL)vs › | $1.36M | 0.00% | 0.00% | 0.00% | 0.00% |
| INVO Fertility, Inc. (IVF)vs › | $1.46M | -70.18% | -240.09% | -517.75% | -505.95% |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.46M | 0.00% | 0.00% | 0.00% | 0.00% |
| Curis, Inc. (CRIS)vs › | $1.48M | -490.33% | -239.03% | -377.20% | -368.58% |
| PMGC Holdings Inc. (ELAB)vs › | $1.46M | -522.97% | -779.71% | -448.59% | -16114.03% |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.20M | -14220.12% | -19831.38% | -10446.98% | -7103.54% |
| Propanc Biopharma, Inc. (PPCB)vs › | $1.17M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-11-30 | 0.00% |
| 2021-08-31 | 0.00% |
| 2021-05-31 | 0.00% |
| 2021-02-28 | 0.00% |
| 2020-11-30 | 0.00% |
| 2020-08-31 | 0.00% |
| 2020-05-31 | 0.00% |
| 2020-02-29 | 0.00% |
| 2019-11-30 | 0.00% |
| 2019-08-31 | 0.00% |
| 2019-05-31 | 0.00% |
| 2019-02-28 | 0.00% |
| 2018-11-30 | 0.00% |
| 2018-08-31 | 0.00% |
| 2018-05-31 | 0.00% |
| 2018-02-28 | 0.00% |
| 2017-11-30 | 0.00% |
| 2017-08-31 | 0.00% |
| 2017-05-31 | 0.00% |
| 2017-02-28 | 0.00% |
| 2016-11-30 | 0.00% |
| 2016-08-31 | 0.00% |
| 2016-05-31 | 0.00% |
| 2016-02-29 | 0.00% |
| 2015-11-30 | 0.00% |
| 2015-08-31 | 0.00% |
| 2015-05-31 | 0.00% |
| 2015-02-28 | 0.00% |
| 2014-11-30 | 0.00% |
| 2014-08-31 | 0.00% |
| 2014-05-31 | 0.00% |
| 2014-02-28 | 0.00% |
| 2013-11-30 | 0.00% |
